Novel Anti-CD40 Monoclonal Antibody CFZ533 in Patients with Primary Sjogren Syndrome: A Phase Iia Double-Blind, Placebo–Controlled Randomized Trial
2018
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
10
Citations
NaN
KQI